menu search

Fda slams brakes on legend biotech's car-t therapy trial in lymphoma patients

The FDA has instituted a clinical hold on Legend Biotech Corporation's (NASDAQ: LEGN) Phase 1 trial for LB1...

February 15, 2022, 9:39 am

Supply chain issues overshadow tesla's earnings beat

Tesla Inc (NASDAQ:TSLA) is down 3.8% to trade at $901.55 at last check, despite the electric vehicle (...

January 27, 2022, 10:27 am

Supply chain issues overshadow tesla's earnings beat

Tesla Inc (NASDAQ:TSLA) is down 3.8% to trade at $901.55 at last check, despite the electric vehicle (...

January 27, 2022, 10:27 am

Supply chain issues overshadow tesla's earnings beat

Tesla Inc (NASDAQ:TSLA) is down 3.8% to trade at $901.55 at last check, despite the electric vehicle (...

January 27, 2022, 10:27 am

Liquidia receives favorable ruling in inter partes review against united therapeutics patent

MORRISVILLE, N.C., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that the U.S. Patent Trial and Appeal Board (...

October 8, 2021, 5:23 pm

Liquidia receives favorable ruling in inter partes review against united therapeutics patent

MORRISVILLE, N.C., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that the U.S. Patent Trial and Appeal Board (...

October 8, 2021, 5:23 pm

Liquidia receives favorable ruling in inter partes review against united therapeutics patent

MORRISVILLE, N.C., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that the U.S. Patent Trial and Appeal Board (...

October 8, 2021, 5:23 pm


Search within

Pages Search Results: